Your browser doesn't support javascript.
loading
Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology.
Fujiwara, Hideaki; Seike, Keisuke; Brooks, Michael D; Mathew, Anna V; Kovalenko, Ilya; Pal, Anupama; Lee, Ho-Joon; Peltier, Daniel; Kim, Stephanie; Liu, Chen; Oravecz-Wilson, Katherine; Li, Lu; Sun, Yaping; Byun, Jaeman; Maeda, Yoshinobu; Wicha, Max S; Saunders, Thomas L; Rehemtulla, Alnawaz; Lyssiotis, Costas A; Pennathur, Subramaniam; Reddy, Pavan.
Afiliação
  • Fujiwara H; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA.
  • Seike K; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA.
  • Brooks MD; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA.
  • Mathew AV; Department of Internal Medicine, Division of Nephrology, University of Michigan Health System, Ann Arbor, MI, USA.
  • Kovalenko I; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
  • Pal A; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Lee HJ; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
  • Peltier D; Department of Pediatrics, Division of Hematology/Oncology and BMT, University of Michigan Health System, Ann Arbor, MI, USA.
  • Kim S; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA.
  • Liu C; Department of Pathology and Laboratory Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
  • Oravecz-Wilson K; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA.
  • Li L; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA.
  • Sun Y; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA.
  • Byun J; Department of Internal Medicine, Division of Nephrology, University of Michigan Health System, Ann Arbor, MI, USA.
  • Maeda Y; Department of Hematology Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Wicha MS; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA.
  • Saunders TL; Transgenic Animal Model Core, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Rehemtulla A; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Lyssiotis CA; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
  • Pennathur S; Department of Internal Medicine, Division of Nephrology, University of Michigan Health System, Ann Arbor, MI, USA.
  • Reddy P; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA. reddypr@med.umich.edu.
Nat Immunol ; 22(11): 1440-1451, 2021 11.
Article em En | MEDLINE | ID: mdl-34686860
ABSTRACT
Intestinal epithelial cell (IEC) damage by T cells contributes to graft-versus-host disease, inflammatory bowel disease and immune checkpoint blockade-mediated colitis. But little is known about the target cell-intrinsic features that affect disease severity. Here we identified disruption of oxidative phosphorylation and an increase in succinate levels in the IECs from several distinct in vivo models of T cell-mediated colitis. Metabolic flux studies, complemented by imaging and protein analyses, identified disruption of IEC-intrinsic succinate dehydrogenase A (SDHA), a component of mitochondrial complex II, in causing these metabolic alterations. The relevance of IEC-intrinsic SDHA in mediating disease severity was confirmed by complementary chemical and genetic experimental approaches and validated in human clinical samples. These data identify a critical role for the alteration of the IEC-specific mitochondrial complex II component SDHA in the regulation of the severity of T cell-mediated intestinal diseases.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Colite / Colo / Citotoxicidade Imunológica / Complexo II de Transporte de Elétrons / Células Epiteliais / Doença Enxerto-Hospedeiro / Mucosa Intestinal / Mitocôndrias Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Colite / Colo / Citotoxicidade Imunológica / Complexo II de Transporte de Elétrons / Células Epiteliais / Doença Enxerto-Hospedeiro / Mucosa Intestinal / Mitocôndrias Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos